Union Health Fund Sues Insulin Makers, PBMs on Price Conspiracy

A Connecticut health benefits fund accused major insulin manufacturers and pharmacy benefit managers of engaging in a widespread deceptive pricing scheme that caused the fund to overpay for diabetes medications.

The International Union of Operating Engineers Local No. 478 Health Benefits Fund filed the complaint Monday in the US District Court for the District of Connecticut. The group alleges insulin makers Eli Lilly and Co., Novo Nordisk Inc., and Sanofi-Aventis U.S. LLC worked together with PBMs like CVS Caremark, Express Scripts, and OptumRx to artificially inflate insulin list prices.

“Although the PBM Defendants represent both publicly ...